Global Health Impact Fund

Global Health Impact Fund (GHIF), established in 2018 and located in Walnut Creek, California, operates as a venture capital investment firm focused on healthcare technology. It caters specifically to a network of clinician and healthcare professional investors, providing them with opportunities to invest in a diversified portfolio of early-stage healthcare companies. GHIF aims to empower healthcare professionals by allowing them to actively participate in the evolving digital healthcare landscape, rather than remaining passive observers of industry changes. The firm emphasizes collaboration among healthcare professionals, fostering a community that shares knowledge on innovative methodologies and digital transformation. Through its strategic investments, GHIF seeks to support businesses that are poised to revolutionize the healthcare industry.

Rachna Goel

General Partner and COO

Gary Goldman

CEO and Founder

Sheetal Nariani

CFO and General Partner

Robert Sweeney

Co-Founder and Principal

3 past transactions

Raydiant Oximetry

Series A in 2024
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth. The company develops a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. It develops and distributes a non-invasive technology that directly monitors a babies' oxygenation during pregnancy. This technology will lead to better patient care and greatly reduce the number of unnecessary cesarean sections. Founded in 2015 by Neil Ray, Raydiant Oximetry is headquartered in Mountain View, California.

Elucid

Series A in 2021
Elucid, located in the Boston biotech and medtech hub, specializes in enhancing the accuracy and cost-effectiveness of cardiovascular diagnostic imaging through machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software that evaluates plaque vulnerability from a single computed tomography angiography (CTA) scan, aiding in the assessment of heart attack and stroke risk as well as treatment selection. The company also collaborates with pharmaceutical firms, healthcare providers, and research organizations to offer quantitative image analysis services. By applying artificial intelligence to vascular diagnostics, Elucid aims to improve patient outcomes while providing a non-invasive and economically efficient means of capturing critical health information, thereby supporting cardiovascular pathologists in delivering comprehensive clinical insights.

Plethy

Seed Round in 2019
Plethy is an InsurTech and HealthTech company focused on enhancing patient outcomes and financial returns for self-insured enterprises, insurance carriers, and health systems. The company has developed a care management platform that helps patients manage their musculoskeletal care from the comfort of their homes or while on the go. This platform integrates a wearable sensor with a software application, allowing patients to adhere to their treatment plans effectively. By leveraging predictive analytics, Plethy provides valuable insights into patient recovery and claims closure, enabling healthcare providers to improve remote monitoring and achieve a balance between quality, access, and cost in patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.